- High gross margin of 90.7%
- Beat earnings estimates in 3 of the last 4 quarters
- Strong return on equity of 65.3%
Adc Therapeutics Ltd stock downgraded from Sell Candidate to Strong Sell Candidate after Tuesday trading session
(Updated on Jul 14, 2026)
The Adc Therapeutics Ltd stock price fell by -1.60% on the last day (Tuesday, 14th Jul 2026) from $1.25 to $1.23. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 3.72% from a day low at $1.21 to a day high of $1.26. The price has risen in 6 of the last 10 days and is up by 19.42% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -76 thousand shares and in total, 558 thousand shares were bought and sold for approximately $685.84 thousand.
The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $1.52 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Due to the high volatility and the trend direction we are not able to give forecast range for this stock. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
ADCT Signals & Forecast
There are mixed signals in the stock today. The Adc Therapeutics Ltd stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.28 and $1.64. A break-up above any of these levels will issue buy signals. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. A buy signal was issued from a pivot bottom point on Monday, June 08, 2026, and so far it has risen 25.81%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for Adc Therapeutics Ltd stock
On the downside, the stock finds support just below today's level from accumulated volume at $1.10 and $1.03. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Adc Therapeutics Ltd finds support just below today's level at $1.10. If this is broken, then the next support from accumulated volume will be at $1.03 and $0.98.
This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.0450 between high and low, or 3.72%. For the last week the stock has had daily average volatility of 6.38%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (ADCT) For The Upcoming Trading Day Of Wednesday 15th
For the upcoming trading day on Wednesday, 15th we expect Adc Therapeutics Ltd to open at $1.23, and during the day (based on 14 day Average True Range), to move between $1.16 and $1.30, which gives a possible trading interval of +/-$0.132 (+/-11.35%) up or down from last closing price. If Adc Therapeutics Ltd takes out the full calculated possible swing range there will be an estimated 11.35% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $1.25 (1.63%) than the support at $1.10 (10.57%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Adc Therapeutics Ltd stock A Buy?
Adc Therapeutics Ltd holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.
Current score:
-5.466
Strong Sell Candidate
Downgraded
Predicted Fair Opening Price
Predicted fair opening price on July 15, 2026 - $1.23 ( 0.136%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
ADCT Performance
Trading levels for ADCT
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 1.28 | 3.79% |
| R2 | 1.26 | 2.40% |
| R1 | 1.25 | 1.53% |
| Price | 1.23 | |
| S1 | 1.21 | -1.26% |
| S2 | 1.20 | -2.13% |
| S3 | 1.19 | -3.52% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 1.35 | 9.76% |
| R2 | 1.32 | 7.32% |
| R1 | 1.25 | 1.63% |
| Price | 1.23 | |
| S1 | 1.10 | -10.57% |
| S2 | 1.03 | -16.26% |
| S3 | 0.98 | -20.51% |
FAQ
Click here for our free guide on how to buy Adc Therapeutics Ltd Stock.
Buy ADCT